Navigation Links
Discovery Promises Simpler Therapy for Sickle Cell Disease

rocess nitric oxide in the blood correspond to the severity of their disease symptoms. That result might explain a long-standing puzzle: patients with sickle cell exhibit extreme variability in the severity of their symptoms, despite the fact that the disease stems from a single genetic defect, Stamler said.

"This finding, if verified in clinical trials, could change physicians' approach to sickle cell disease," Stamler said. "Current efforts for managing the disease completely miss the role that red blood cell-derived nitric oxide plays. The disease might therefore be treated by more simple and effective methods than those now available to patients through the delivery of nitric oxide to blood cells."

The finding marks the first time that a defect in the ability of patients' red blood cells to process nitric oxide has been linked to a disease, the researchers said. The findings also raise the possibility that defective nitric oxide processing by red blood cells may represent a new class of blood diseases.

Patients with sickle cell disease have an abnormal form of hemoglobin. In the late 1990s, Stamler's team discovered that, in addition to its role in oxygen delivery, hemoglobin acts a biosensor, adjusting blood flow according to the oxygen demand of tissues and organs, by distributing nitric oxide.

Reports by the team in 2001 and 2002 further detailed nitric oxide's role in the red blood cell membrane, confirming it as the third major blood gas, along with oxygen and carbon dioxide. Those findings suggested that nitric oxide defects might play a role in the cardiovascular side effects of many disorders, including diabetes, heart attacks, septic shock and sickle cell disease.

In the current study, the researchers found that hemoglobin in the red cells of patients with sickle cell disease fails to process nitric oxide properly. As a result, they reported, the membranes of sickle red blood cells are deficient for the form of ni
'"/>

Source:DukeMedNews


Page: 1 2 3

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Could Lead To Novel Approaches In HIV Treatment
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Discovery Promises Simpler Therapy for Sickle Cell Disease

(Date:6/30/2015)... 2015 To bolster its efforts and commitment to ... today the addition of two new team members. ... and David Raviv will act as head of ... commitment to providing the most secure solutions for the enterprise ... Layer 7 Technologies, a provider of security and management products, ...
(Date:6/29/2015)... June 24, 2015 Research ... the "Latin America Biomedical Sensors Market - Growth, ... The Latin America Biomedical Sensors market is ... of 2.04% over the period 2014-2020 The ... to the genetic formulation of each individual. These sensors ...
(Date:6/25/2015)... , June 25, 2015 ... Sensors Market by Type (Swipe & Area), Technology, Material ... Government, Healthcare, Commercial Security & Others) & Geography ... by marketsandmarkets, the said market is expected to ... of 17.1%. Browse 76 market ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
... of scientists has produced a new type of rice ... other rice crops. Professor Andy Pereira at the Virginia ... India, Indonesia, Israel, Italy, Mexico and The Netherlands to ... as HARDY that improves key features of this important ...
... where the Andes meet the Amazon and is locally grown ... the Pacific. It is produced in three species which are ... has resulted in fertile and stable hybrids. This gives it ... quality food production and offer a sustainable cropping system that ...
... Recently, researchers at Iowa State University discovered a way ... By zeroing in on early stages leading up to ... predictions across a variety of environmental conditions. The team ... of Crop Science. The Crop Environment Resource Synthesis ...
Cached Biology News:HARDY rice: less water, more food 2HARDY rice: less water, more food 3Yam bean a nearly forgotten crop 2Simulating kernel production influences maize model accuracy 2
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... OF PRUSSIA, Pa. , July 28, 2015 /PRNewswire/ ... U.S. Food and Drug Administration has accepted for review ... investigational recombinant factor VIII single-chain (rVIII-SingleChain) for the treatment ... met all primary endpoints. Hemophilia ... deficient or defective factor VIII; nearly all affected patients ...
(Date:7/28/2015)... and RESEARCH TRIANGLE PARK, N.C., July 28, 2015 /PRNewswire/ ... announced its financial results for the second quarter ... grew nearly 300% as compared to the second ... launched," said Roger Jeffs, Ph.D., United Therapeutics, President ... sales was due to an increase in the ...
(Date:7/28/2015)...  Faced with increasing challenges such as costly ... symptomatic, the global healthcare industry today is gradually ... curing or significantly changing the course of a ... regenerative medicine as a viable alternative. ... health with the potential to resolve unmet medical ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5
... Systems and Tip Revenue Up Domestically and Internationally ... U.S. Sales Increase 8% Year-Over-Year ... HAYWARD, Calif., May 8 Thermage, Inc.,(Nasdaq: THRM ), ... its financial results for the first quarter ended,March 31, 2008., ...
... Company History; Full Year Revenue Up 13% Non-GAAP ... Year Company Provides FY09 Outlook for 13 ... May 8 Pharsight,Corporation (Nasdaq: PHST ), a ... clinical drug development, today announced,financial results for its fiscal ...
... 8 Favrille, Inc. (Nasdaq:,FVRL), a biopharmaceutical company ... today reported its financial,results for the first quarter ... was $10.5 million, or $0.25 per share, compared ... same period in 2007., (Logo: http://www.newscom.com/cgi-bin/prnh/20080404/LAF521LOGO ...
Cached Biology Technology:Thermage Announces First Quarter 2008 Financial Results 2Thermage Announces First Quarter 2008 Financial Results 3Thermage Announces First Quarter 2008 Financial Results 4Thermage Announces First Quarter 2008 Financial Results 5Thermage Announces First Quarter 2008 Financial Results 6Thermage Announces First Quarter 2008 Financial Results 7Thermage Announces First Quarter 2008 Financial Results 8Thermage Announces First Quarter 2008 Financial Results 9Pharsight Achieves $7.6 Million In Quarterly Revenue 2Pharsight Achieves $7.6 Million In Quarterly Revenue 3Pharsight Achieves $7.6 Million In Quarterly Revenue 4Pharsight Achieves $7.6 Million In Quarterly Revenue 5Pharsight Achieves $7.6 Million In Quarterly Revenue 6Pharsight Achieves $7.6 Million In Quarterly Revenue 7Pharsight Achieves $7.6 Million In Quarterly Revenue 8Pharsight Achieves $7.6 Million In Quarterly Revenue 9Pharsight Achieves $7.6 Million In Quarterly Revenue 10Pharsight Achieves $7.6 Million In Quarterly Revenue 11Pharsight Achieves $7.6 Million In Quarterly Revenue 12Favrille Reports First Quarter 2008 Financial Results 2Favrille Reports First Quarter 2008 Financial Results 3Favrille Reports First Quarter 2008 Financial Results 4Favrille Reports First Quarter 2008 Financial Results 5Favrille Reports First Quarter 2008 Financial Results 6Favrille Reports First Quarter 2008 Financial Results 7Favrille Reports First Quarter 2008 Financial Results 8Favrille Reports First Quarter 2008 Financial Results 9
Packaging: 6 bottles for 1 l ready-to-use-solution ID clarifier: ready-to-use solution ...
... are neutral, porous styrene divinylbenzene ... of lipophilic polymers and other ... The beads are compatible with ... dimethylformamide, ketones, aromatics, methylene chloride, ...
15(S)-HEDE is produced from 11Z,14Z-eicosadienoic acid by 15-LO. 15(S)-HEDE is an inhibitor of RBL-1 cell 5-LO with an IC50 value of 26 µM....
Simple operation and an easy-to-read LCD display characterize our Classic Light balances. * Taring range 0...1510 g...
Biology Products: